When: Daily close below $347 on volume >10M

Then: Exit to Underweight

HOLD - maintain existing exposure with defined stop, trim, and add levels

• MACD bearish crossover occurred AFTER a 23% advance, with histogram deepening from negative 0.20 to negative 1.23 over six weeks of failed breakouts above $365-$371, indicating distribution not accumulation
• 24x forward multiple already reflects the 28% EPS upgrades - market does not give credit twice for the same upgrade
• PEG of 1.64 is elevated by any reasonable framework; Trefis flagged margin assumptions supporting the multiple as vulnerable
• BioCatch $2.4 billion acquisition paid in cash at the top of a 23% rally, with net debt growing 43% YoA to $11.5 billion despite $20 billion annual FCF
• DOJ debit case is a binary and slow-moving tail risk that markets price poorly; should not add ahead of trial date
• Mastercard's services revenue grew 20% YoY vs Visa's undisclosed pace - Visa losing relative services franchise battle
• Buybacks at $362 (30x trailing earnings) are value-destructive if multiple compresses; retirement rate is 3% annually
• Stop level at $347 is approximately 2x ATR below the 50-day moving average
• Trim 10-15% of position if stock rallies into $370-$374 resistance zone
• Add trigger at $374 on decisive confirmation with volume and MACD crossing zero

→ vs aggressive: MACD comparison to March 2026 is invalid - March 2026 was a capitulation at lows with oversold conditions; current setup is distribution at higher levels after a 23% rally, categorically different price action

→ vs aggressive: Buying at $362.82 into a six-week consolidation that has failed six times at $365-$371 is buying into a ceiling, not a coiled spring; defined add trigger at $374 with MACD confirmation exists for upside participation

→ vs aggressive: 24x forward is not a discount - the multiple has already compressed to reflect the 28% EPS upgrades; PEG of 1.64 is elevated and BioCatch integration costs are not fully reflected in consensus

→ vs aggressive: DOJ case is not 'already priced' - markets price binary and slow-moving risks poorly; if DOJ wins on market definition and interchange caps broaden, the multiple compresses regardless of fundamentals

→ vs aggressive: MA outperformance is not a 'one-week tape divergence' - 20% services revenue growth is a fundamental signal that MA is winning the high-margin services franchise battle; Visa's relative underperformance will continue if MA extends this lead

→ vs aggressive: BioCatch optionality is actually execution risk - $2.4 billion cash outlay at elevated multiples, competing with buybacks for capital, and net debt up 43% YoA is not asymmetric upside; it's a leveraged bet at the top of the tape

→ vs aggressive: Buybacks at 30x trailing earnings reduce share count at potentially unsustainable prices; adding at $362 at the same elevated level management is buying is herd behavior, not margin of safety

→ vs aggressive: Macro tailwinds (8% recession odds, Fed on hold) are already priced into the 24x forward multiple - they provide no additional margin of safety, only confirmation of current valuation

HOLD - maintain core position with stop at 347 and trim levels at 370-374; allow small tactical starter add (25-50% of full aggressive add) on weakness toward 350-355

• MACD comparison to March 2026 is broken: current setup is distribution at higher levels post-rally, not base-building recovery; histogram deepened from negative 0.20 to negative 1.23 over six weeks of failed breakouts above 365-371
• Fundamental picture is genuinely strong: 50 SMA above 200 SMA, golden cross regime, best-in-class franchise quality, 24x forward multiple reasonable for this growth profile
• Buybacks are accretive at 30x earnings given 61% ROE; conservative analyst's framing that buybacks at 362 are value-destructive is technically incorrect
• DOJ case is slow-moving regulatory overhang, not a black swan; market has had years to digest it and legal experts view Visa's market definition defense as credible
• Macro setup is supportive: 8% recession odds, no rate cuts priced for 2026, sticky but not accelerating inflation, resilient consumer spending backdrop
• BioCatch acquisition ($2.4B cash) creates near-term amortization drag and integration risk; not free optionality but real capital bet at potentially suboptimal entry point
• MA underperformance on services revenue (20% YoY growth) is a fundamental signal about mix shift toward higher-margin services; Visa losing relative-value battle to its closest peer
• MA underperformance is a yellow flag, not a red flag: justifies not aggressively adding but not a reason to sell a name with 66% operating margin and 50% profit margin at 24x forward P/E
• Position sizing should reflect genuine uncertainty: mix of best-in-class franchise with deteriorating technicals, regulatory overhang, and acquisition risk

→ vs aggressive: MACD analogy to March 2026 is pattern-matching to wrong regime entirely; current bearish crossover occurred AFTER a 23% advance, not at the bottom of a decline

→ vs aggressive: BioCatch is real execution risk and integration burden, not free asymmetric optionality; $2.4B cash outlay at elevated multiples creates near-term amortization drag

→ vs aggressive: MA outperformance on services revenue (20% YoY) is a fundamental signal about mix shift and higher-margin services; cheaper for a reason and Visa is losing the relative-value battle

→ vs conservative: Buyback framing is technically incorrect; accretion is real at any reasonable multiple when ROE (61%) exceeds cost of equity, and cash on balance sheet earns near nothing

→ vs conservative: DOJ case has been hanging over Visa for years; market has had ample time to digest it and legal experts find the market definition defense credible

→ vs conservative: Macro setup is not fully priced; 8% recession odds, no rate cuts for 2026, and resilient consumer are genuine tailwinds helping Visa grind higher regardless of technical pattern

→ vs conservative: Managing tail risk by inaction is the wrong tool for the job during a compounder's consolidation; leave room for tactical positioning